How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | BAXBAXTER INTERNATIONAL INC | RMDRESMED INC | GEHCGE HealthCare Technologies Inc. | DXCMDEXCOM INC | Median of the restexcluding BAX |
|---|---|---|---|---|---|
| Type | Company | Company | Company | Company | |
| Price | $25.65▲ 0.95 (3.85%) | $253.06▲ 6.86 (2.79%) | $71.42▲ 2.41 (3.49%) | $80.26▼ 5.48 (6.39%) | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 5.0/10 | 9.0/10 | 8.7/10 | 8.7/10 | 8.7/10 |
| Market value | $13.12B | $36.50B | $32.66B | $30.88B | |
| Revenue | $11.24B | $5.65B | $20.63B | $4.66B | |
| Profit | -$957.0M | $1.52B | $2.08B | $836.3M | |
| Revenue growthChange in sales versus the prior year. | 5.7% | 9.9% | 4.8% | 15.6% | 9.9% |
| Gross marginShare of sales left after the direct cost of producing them. | 30.1% | 61.1% | 40.0% | 60.1% | 60.1% |
| Operating marginShare of sales left after running the business, before interest and tax. | -2.7% | 33.4% | 13.4% | 19.6% | 19.6% |
| Profit marginProfit kept from each dollar of sales. | -8.5% | 26.9% | 10.1% | 17.9% | 17.9% |
| Free cash flow marginCash left after capital spending, as a share of sales. | 3.0% | 29.2% | 7.3% | 23.1% | 23.1% |
| Return on equityProfit against the owners' stake in the company. | -15.6% | 23.1% | 20.1% | 30.5% | 23.1% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | -1.8% | 25.9% | 13.1% | 38.3% | 25.9% |
| P/E ratioPrice paid per dollar of annual profit. | — | 23.96x | 15.67x | 36.93x | 23.96x |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | 30.60x | 17.09x | 12.51x | — | 14.80x |
| Price to book | 2.14x | 5.54x | 3.15x | 11.25x | 5.54x |
| Debt to equityTotal liabilities compared with owners' stake. | 2.28x | 0.36x | 2.53x | 1.31x | 1.31x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 6/9 | 8/9 | 5/9 | 7/8 | 7.0 |
| Bankruptcy riskAltman Z-Score zone. | grey | safe | grey | safe |
How BAX compares with the others
- BAX's operating margin of -2.7% is lower than the median of the other companies selected (19.6%).
- Its revenue grew more slowly than the median of the other companies selected: 5.7% against 9.9%.
- It has no P/E to set against theirs, because it did not make a profit.
- Its liabilities are higher relative to equity than the median of the other companies selected: 2.3x against 1.3x.
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.